ID: ALA5201219

Chembl Id: CHEMBL5201219

PubChem CID: 168290268

Max Phase: Preclinical

Molecular Formula: C20H26N2

Molecular Weight: 294.44

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H]1C[C@@H]2C[C@H]3c4c(c5ccccc5n4C)CCN(C2)[C@@H]13

Standard InChI:  InChI=1S/C20H26N2/c1-3-14-10-13-11-17-19(14)22(12-13)9-8-16-15-6-4-5-7-18(15)21(2)20(16)17/h4-7,13-14,17,19H,3,8-12H2,1-2H3/t13-,14+,17-,19+/m1/s1

Standard InChI Key:  LXGQJDWIMJPUFD-AHMDFLBRSA-N

Alternative Forms

  1. Parent:

    ALA5201219

    ---

Associated Targets(Human)

SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Slc18a2 Synaptic vesicular amine transporter (631 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 294.44Molecular Weight (Monoisotopic): 294.2096AlogP: 3.94#Rotatable Bonds: 1
Polar Surface Area: 8.17Molecular Species: BASEHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.02CX LogP: 3.91CX LogD: 2.29
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.77Np Likeness Score: 0.82

References

1. Kargbo RB..  (2022)  Ibogaine and Their Analogs as Therapeutics for Neurological and Psychiatric Disorders.,  13  (6.0): [PMID:35707155] [10.1021/acsmedchemlett.2c00214]

Source